MedDataX Logo

Metacognitive Therapy for Comorbid Insomnia

NCT ID: NCT00235365

Last Updated: 2012-11-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2009-08-31

Study Completion Date

2011-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the effect of meta-cognitive therapy for insomnia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a randomized controlled trial with 50 patients with a psychiatric disorder and insomnia. The patients will be randomized into two groups of 25 patients. The first group receives meta-cognitive therapy, whereas the second group will be assigned to a waiting list control.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Secondary Insomnia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

meta-cognitive therapy

meta-cognitive therapy

Group Type EXPERIMENTAL

meta-cognitive therapy

Intervention Type BEHAVIORAL

Meta-cognitive therapy

waiting list

waiting list control

Group Type ACTIVE_COMPARATOR

waiting list

Intervention Type OTHER

waiting list control

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

meta-cognitive therapy

Meta-cognitive therapy

Intervention Type BEHAVIORAL

waiting list

waiting list control

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Insomnia secondary to a primary psychiatric disorder

Exclusion Criteria

* substance abuse, psychotic symptoms, suicidal intentions, severe organic disorder or psychiatric disorder where sleep restriction is not advised, organic sleep disorder.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Norwegian University of Science and Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gunnar Morken, PhD MD

Role: PRINCIPAL_INVESTIGATOR

Norwegian University of Science and Technology

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S2005.2.gr

Identifier Type: -

Identifier Source: org_study_id